Medication Errors in Pediatric Patients after Implementation of a Field Guide with Volume-Based Dosing

Lara D Rappaport1,2, Geoffrey Markowitz2, Steven Hulac3

  • 1Department of Emergency Medicine, Denver Health Medical Center, Denver, Colorado.

Insights

Implementing a precalculated pediatric dose guide significantly improved medication accuracy in prehospital care. The Handtevy Field Guide reduced dosing errors, enhancing patient safety for children during emergencies.

Area of Science:

  • Emergency Medicine
  • Pediatric Care
  • Prehospital Services

Background:

  • Pediatric medication errors are frequent among prehospital providers.
  • A hospital-based urban EMS system introduced the Handtevy Field Guide in 2015.
  • The guide provides precalculated pediatric doses in milliliters (mL) by patient age.

Purpose of the Study:

  • To evaluate the impact of the Handtevy Field Guide on pediatric medication dosing accuracy.
  • To determine if the implementation increased correct pediatric medication doses to over 85%.

Main Methods:

  • Retrospective cohort study of pediatric patients (< 13 years) from August 2017 to July 2019.
  • Compared medication administrations to 2014 baseline data using electronic medical records.
  • Defined correct doses as 80-120% of the Field Guide recommendation; excluded nebulized and online-directed medications.

Main Results:

  • Correct doses were administered in 89.4% of cases during the study period, up from 51.1% at baseline (p < 0.001).
  • Specific medications like adenosine, dextrose 10%, and epinephrine 1:10,000 had 100% appropriate dosing.
  • Medication errors included overdoses (4.4%) and underdoses (6.2%), with highest error rates in infants (0-1 year).

Conclusions:

  • Implementation of a precalculated mL dose system by patient age improved pediatric medication administration accuracy.
  • A field guide with precalculated doses is an effective tool for reducing pediatric medication dosing errors by EMS providers.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
12
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
10